These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9395142)

  • 41. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.
    Johnston JM; Harmon SA; Binn LN; Richards OC; Ehrenfeld E; Summers DF
    J Infect Dis; 1988 Jun; 157(6):1203-11. PubMed ID: 2836522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
    Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL
    J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative.
    Carlsson U; Brudin L; Eliasson I; Hansson BG
    Scand J Infect Dis; 1996; 28(5):435-8. PubMed ID: 8953668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid bioassay of human interferon by direct enzyme immunoassay of encephalomyocarditis virus in HEp-2 cell monolayers after a single cycle of infection.
    Vlaspolder F; Donkers E; Harmsen T; Kraaijeveld CA; Snippe H
    J Virol Methods; 1989; 24(1-2):153-8. PubMed ID: 2474560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology.
    Crance JM; Passagot J; Biziagos E; Deloince R
    J Virol Methods; 1987 Nov; 18(2-3):193-203. PubMed ID: 2828401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Properties and characterization of monoclonal antibodies to Tacaribe virus.
    Howard CR; Lewicki H; Allison L; Salter M; Buchmeier MJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1383-95. PubMed ID: 2410550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus.
    Schofield DJ; Satterfield W; Emerson SU; Purcell RH
    Virology; 2002 Jan; 292(1):127-36. PubMed ID: 11878915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A.
    Delem A; Safary A; De Namur F; Hauser P; D'Hondt E
    Vaccine; 1993; 11(4):479-84. PubMed ID: 8385844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis a outbreak in a public school in Rio de Janeiro, Brazil.
    Villar LM; Esteves da Costa Mdo C; de Paula VS; Gaspar AM
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):301-5. PubMed ID: 12048555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity.
    Krah DL
    Biologicals; 1991 Jul; 19(3):223-7. PubMed ID: 1659431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preparation and characteristics of cultured strains of hepatitis A virus from humans and monkeys].
    Korzaia LI; Shevtsova ZV; Lapin BA; D'iachenko AG; Krylova RI
    Vopr Virusol; 1997; 42(2):60-3. PubMed ID: 9182400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct enzyme immunoassay for detection of specific IgG antibody to rubella virus by use of labelled antigen.
    Bonfanti C; Meurman O; Halonen P
    J Virol Methods; 1985 Jun; 11(2):161-70. PubMed ID: 3894404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of hepatitis A propagation in tissue culture with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
    Widell A; Hansson BG; Nordenfelt E; Oberg B
    J Med Virol; 1988 Apr; 24(4):369-76. PubMed ID: 2835431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New method for titration of virus infectivity by immunostaining.
    Usuba O; Schulman JL; Deatly AM; Bona CA; Moran TM
    Viral Immunol; 1990; 3(3):237-41. PubMed ID: 2175196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.
    Rosen E; Stapleton JT; McLinden J
    Vaccine; 1993; 11(7):706-12. PubMed ID: 8393604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Algorithm for specific laboratory diagnosis in viral hepatitis among inpatients (lecture)].
    Simonova IA; Volchkova EV; Chulanov VP; Pak SG; Ol'shanskiĭ AIa
    Klin Lab Diagn; 2000 Aug; (8):21-33. PubMed ID: 11031429
    [No Abstract]   [Full Text] [Related]  

  • 59. Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in Turkey.
    Colak D; Ogunc D; Gunseren F; Velipasaoglu S; Aktekin MR; Gültekin M
    Acta Microbiol Immunol Hung; 2002; 49(1):93-7. PubMed ID: 12073829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines.
    Su Q; Guo M; Jia Z; Qiu F; Lu X; Gao Y; Meng Q; Tian R; Bi S; Yi Y
    J Virol Methods; 2016 Jul; 233():41-5. PubMed ID: 26994964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.